cancer drug
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
cancer drug
Apr 21, 2024, 21:27 |
Drugs
Hagop Kantarjian: We review the evidence leading to Tagraxofusp approval as first in class CD123-directed drug which has changed the field of BPDCN
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X: “Tazgraxofusp is…
Aug 16, 2023, 19:07 |
Drugs
Ben Derman: Some thoughts on Elrantamab in light of approval.
Dr. Ben Derman, Assistant Professor at the University of Chicago, recently shared in a Twitter…
Jul 11, 2023, 16:56 |
Blog
COA has submitted formal comments to Congress on the ongoing cancer drug shortage crisis - Community Oncology Alliance
COA has submitted formal comments to Congress on the ongoing cancer drug shortage crisis and…
Jun 2, 2023, 21:13 |
Drugs
Advocating for Children with Cancer: Proposed Revision of European Pharmaceutical Legislation
"The European Commission proposed the revision of the European pharmaceutical legislation in April. After years…
All:
4
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube